Manulife (Manufacturers Life Insurance)
DNTH icon

Manulife (Manufacturers Life Insurance)’s Dianthus Therapeutics DNTH Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.12M Sell
62,829
-2,409
-4% -$210K ﹤0.01% 1117
2026
Q1 		$5.47M Buy
65,238
+39,640
+155% +$2.3M ﹤0.01% 1122
2025
Q4 		$1.05M Buy
25,598
+6,816
+36% +$264K ﹤0.01% 1826
2025
Q3 		$739K Buy
+18,782
New +$480K ﹤0.01% 2026
2024
Q4 		– Sell
-8,883
Closed -$243K – 2984
2024
Q3 		$243K Sell
8,883
-219
-2% -$6.1K ﹤0.01% 2575
2024
Q2 		$236K Buy
+9,102
New +$219K ﹤0.01% 2539
2021
Q3 		– Sell
-1,234
Closed -$193K – 3163
2021
Q2 		$193K Buy
1,234
+344
+39% +$63.2K ﹤0.01% 3125
2021
Q1 		$169K Sell
890
-49
-5% -$8.25K ﹤0.01% 2952
2020
Q4 		$118K Buy
939
+156
+20% +$17.7K ﹤0.01% 2933
2020
Q3 		$85K Buy
783
+53
+7% +$6.28K ﹤0.01% 2829
2020
Q2 		$87K Sell
730
-117
-14% -$16.5K ﹤0.01% 2787
2020
Q1 		$85K Buy
847
+28
+3% +$5.19K ﹤0.01% 2626
2019
Q4 		$199K Sell
819
-22
-3% -$4.11K ﹤0.01% 2607
2019
Q3 		$130K Buy
841
+7
+0.8% +$1.33K ﹤0.01% 2755
2019
Q2 		$197K Buy
+834
New +$206K ﹤0.01% 2664

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s DNTH Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Dianthus Therapeutics (DNTH) stake by 3.7% in Q2 2026, selling an estimated $210K and leaving 62,829 shares worth $6.12M. The position accounts for ﹤0.01% of the portfolio, ranked #1117.

Manulife (Manufacturers Life Insurance) first reported a position in DNTH in Q2 2019 and has held it in 15 quarters since. 268 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 62,829 shares of Dianthus Therapeutics worth $6.12M as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) sold 2,409 Dianthus Therapeutics shares in Q2 2026, an estimated $210K.
  • Dianthus Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #1117 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Dianthus Therapeutics in Q2 2019 and has held it in 15 quarters since.
  • 268 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.